Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (271-280 of 522) with videos related to

Pageof 53
Sort By:
European Urology Oncology|April 19, 2020
Intermediate-risk Prostate Cancer: Stratification and ManagementFelix Preisser, Matthew R Cooperberg, Juanita Crook, et al.
European Urology|April 28, 2015
Genomic Predictors of Outcome in Prostate CancerPeter J Boström, Anders S Bjartell, James W F Catto, et al.
Cancer|August 10, 2016
Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancerColette A Whitney, Lauren E Howard, Christopher L Amling, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 15, 2015
Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital databaseDaniel F Zapata, Lauren E Howard, William J Aronson, et al.
European Urology|February 25, 2020
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Timothy J Wilt, Tien N Vo, Lisa Langsetmo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2014
Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH databaseEmma H Allott, Lauren E Howard, Matthew R Cooperberg, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2023
The natural history of a delayed detectable PSA after radical prostatectomyJulie A Szymaniak, Samuel L Washington, Janet E Cowan, et al.
The Journal of Sexual Medicine|February 23, 2023
Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record?Farnoosh Nik-Ahd, Justin Waller, Amanda M De Hoedt, et al.
The Journal of Pathology|August 7, 2023
Club-like cells in proliferative inflammatory atrophy of the prostateFranklin W Huang, Hanbing Song, Hannah Nw Weinstein, et al.
European Urology|May 23, 2025
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare DataKevin D Li, Marvin N Carlisle, Stephanie Jarosek, et al.
Pageof 53

Showing results (271-280 of 522) with videos related to

Sort By:
Pageof 53
European Urology Oncology|April 19, 2020
Intermediate-risk Prostate Cancer: Stratification and ManagementFelix Preisser, Matthew R Cooperberg, Juanita Crook, et al.
European Urology|April 28, 2015
Genomic Predictors of Outcome in Prostate CancerPeter J Boström, Anders S Bjartell, James W F Catto, et al.
Cancer|August 10, 2016
Race does not predict the development of metastases in men with nonmetastatic castration-resistant prostate cancerColette A Whitney, Lauren E Howard, Christopher L Amling, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 15, 2015
Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital databaseDaniel F Zapata, Lauren E Howard, William J Aronson, et al.
European Urology|February 25, 2020
Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)Timothy J Wilt, Tien N Vo, Lisa Langsetmo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2014
Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH databaseEmma H Allott, Lauren E Howard, Matthew R Cooperberg, et al.
Prostate Cancer and Prostatic Diseases|February 10, 2023
The natural history of a delayed detectable PSA after radical prostatectomyJulie A Szymaniak, Samuel L Washington, Janet E Cowan, et al.
The Journal of Sexual Medicine|February 23, 2023
Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record?Farnoosh Nik-Ahd, Justin Waller, Amanda M De Hoedt, et al.
The Journal of Pathology|August 7, 2023
Club-like cells in proliferative inflammatory atrophy of the prostateFranklin W Huang, Hanbing Song, Hannah Nw Weinstein, et al.
European Urology|May 23, 2025
Evolving Risk of Urinary Adverse Events Across Localized Prostate Cancer Treatments: A Propensity-weighted Analysis of Surveillance, Epidemiology and End Results-Medicare DataKevin D Li, Marvin N Carlisle, Stephanie Jarosek, et al.
Pageof 53